These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39253611)

  • 1. Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's disease.
    Qian K; Yang P; Li Y; Meng R; Cheng Y; Zhou L; Wu J; Xu S; Bao X; Guo Q; Wang P; Xu M; Sheng D; Zhang Q
    Asian J Pharm Sci; 2024 Aug; 19(4):100938. PubMed ID: 39253611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer's Disease.
    Qian K; Bao X; Li Y; Wang P; Guo Q; Yang P; Xu S; Yu F; Meng R; Cheng Y; Sheng D; Cao J; Xu M; Wu J; Wang T; Wang Y; Xie Q; Lu W; Zhang Q
    ACS Nano; 2022 Jul; 16(7):11455-11472. PubMed ID: 35839463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.
    Reddy PH; Manczak M; Kandimalla R
    Hum Mol Genet; 2017 Apr; 26(8):1483-1496. PubMed ID: 28186562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction.
    Jin H; Liu T; Wang WX; Xu JH; Yang PB; Lu HX; Sun QR; Hu HT
    Neurochem Int; 2010 Feb; 56(3):417-23. PubMed ID: 19941922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.
    Jia YL; Wang W; Han N; Sun HL; Dong FM; Song YX; Feng RF; Wang JH
    Biochem Biophys Res Commun; 2023 May; 658():36-43. PubMed ID: 37018887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.
    Manczak M; Mao P; Calkins MJ; Cornea A; Reddy AP; Murphy MP; Szeto HH; Park B; Reddy PH
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S609-31. PubMed ID: 20463406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanin; a defender against Alzheimer's disease?
    Matsuoka M
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):37-42. PubMed ID: 19149712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease.
    Guo Q; Li Y; Xu S; Wang P; Qian K; Yang P; Sheng D; Wang L; Cheng Y; Meng R; Cao J; Luo H; Wei Y; Zhang Q
    J Control Release; 2023 Mar; 355():604-621. PubMed ID: 36738970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platycodon grandiflorum root extract inhibits Aβ deposition by breaking the vicious circle linking oxidative stress and neuroinflammation in Alzheimer's disease.
    Nam Y; Ji YJ; Shin SJ; Park HH; Yeon SH; Kim SY; Son RH; Jang GY; Kim HD; Moon M
    Biomed Pharmacother; 2024 Aug; 177():117090. PubMed ID: 38968796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor.
    Ying G; Iribarren P; Zhou Y; Gong W; Zhang N; Yu ZX; Le Y; Cui Y; Wang JM
    J Immunol; 2004 Jun; 172(11):7078-85. PubMed ID: 15153530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice.
    Jia YL; Sun SJ; Chen JH; Jia Q; Huo TT; Chu LF; Bai JT; Yu YJ; Yan XX; Wang JH
    Curr Alzheimer Res; 2016; 13(3):297-306. PubMed ID: 26679857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.
    Guo Q; Xu S; Yang P; Wang P; Lu S; Sheng D; Qian K; Cao J; Lu W; Zhang Q
    J Control Release; 2020 Apr; 320():347-362. PubMed ID: 31978446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.
    Chang R; Al Maghribi A; Vanderpoel V; Vasilevko V; Cribbs DH; Boado R; Pardridge WM; Sumbria RK
    Mol Pharm; 2018 Nov; 15(11):4963-4973. PubMed ID: 30252487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats.
    Yuan L; Liu XJ; Han WN; Li QS; Wang ZJ; Wu MN; Yang W; Qi JS
    Neurosci Bull; 2016 Aug; 32(4):374-82. PubMed ID: 27306655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.